title: Viewpoint: personalizing statin therapy.
abstract: Cardiovascular disease (CVD), associated with vascular atherosclerosis, is the major cause of death in Western societies. Current risk estimation tools, such as Framingham Risk Score (FRS), based on evaluation of multiple standard risk factors, are limited in assessment of individual risk. The majority (about 70%) of the general population is classified as low FRS where the individual risk for CVD is often underestimated but, on the other hand, cholesterol lowering with statin is often excessively administered. Adverse effects of statin therapy, such as muscle pain, affect a large proportion of the treated patients and have a significant influence on their quality of life. Coronary artery calcification (CAC), as assessed by computed tomography, carotid artery intima-media thickness (CIMT), and especially presence of plaques as assessed by B-mode ultrasound are directly correlated with increased risk for cardiovascular events and provide accurate and relevant information for individual risk assessment. Absence of vascular pathology as assessed by these imaging methods has a very high negative predictive value and therefore could be used as a method to reduce significantly the number of subjects who, in our opinion, would not benefit from statins and only suffer from their side-effects. In summary, we suggest that in very-low-risk subjects, with the exception of subjects with low FRS with a family history of coronary artery disease (CAD) at young age, if vascular imaging shows no CAC or normal CIMT without plaques, statin treatment need not be administered.
authors.affiliation: Internal Medicine A, The Rappaport Family Institute for Research in the Medical Sciences, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and Rambam Medical Center, Haifa, Israel; and ; Lipid Research Laboratory, The Rappaport Family Institute for Research in the Medical Sciences, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and Rambam Medical Center, Haifa, Israel.
authors.forename: Shlomo
authors.initials: S
authors.lastname: Keidar
authors.forename: Aviva
authors.initials: A
authors.lastname: Gamliel-Lazarovich
keywords: Framingham Risk Score; atherosclerosis; cardiovascular disease; carotid artery intima-media thickness; coronary artery calcification; statin
references.citation: JAMA. 1986 Nov 28;256(20):2823-8
references.pmid: 3773199
references.citation: Eur Heart J. 2013 Apr;34(14):1075-82
references.pmid: 23303659
references.citation: J Am Coll Cardiol. 2003 May 7;41(9):1475-9
references.pmid: 12742284
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816
references.pmid: 23440795
references.citation: J Am Coll Cardiol. 2005 Nov 15;46(10):1931-6
references.pmid: 16286182
references.citation: Lancet. 2012 Aug 11;380(9841):581-90
references.pmid: 22607822
references.citation: JACC Cardiovasc Imaging. 2009 Jun;2(6):675-88
references.pmid: 19520336
references.citation: Arch Intern Med. 2010 Jun 28;170(12):1024-31
references.pmid: 20585067
references.citation: Lancet. 2012 Aug 11;380(9841):565-71
references.pmid: 22883507
references.citation: Curr Atheroscler Rep. 2011 Oct;13(5):422-30
references.pmid: 21792639
references.citation: Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):871-5
references.pmid: 22748604
references.citation: J Am Coll Cardiol. 2010 Jul 6;56(2):98-105
references.pmid: 20620724
references.citation: JAMA. 2007 Mar 28;297(12):1376-8
references.pmid: 17384436
references.citation: JAMA. 2009 Dec 2;302(21):2345-52
references.pmid: 19952321
references.citation: Radiology. 2003 Nov;229(2):340-6
references.pmid: 14500855